Atlas Trials

Vandetanib in Advanced NSCLC With RET Rearrangement

Clinical trial NCT01823068 · COMPLETED

Trial details

NCT number
NCT01823068
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2014-11-03
Primary completion
2014-12-29
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.